Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.076 | 0.7 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |